| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $517.1M | +16.0% |
| Gross Profit | $362.5M | +21.6% |
| R&D Expense | $70.8M | +2.2% |
| SG&A Expense | $110.8M | +0.2% |
| Operating Income | $57.8M | +257.9% |
| Pre-tax Income | $68.2M | +164.9% |
| Income Tax | $1.8M | +15.1% |
| Net Income | $66.4M | +174.9% |
| EPS (Basic) | $0.84 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $362.6M | +51.7% |
| Accounts Receivable | $44.7M | -4.0% |
| Inventory | $20.5M | -5.5% |
| Current Assets | $488.4M | +31.2% |
| Total Assets | $1.41B | +8.2% |
| Current Liabilities | $59.9M | -23.8% |
| Total Liabilities | $96.4M | -22.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $136.3M | +81.5% |
| Capital Expenditures | $9.7M | -14.3% |
| Investing Cash Flow | -$9.2M | +83.6% |
| Financing Cash Flow | -$4.2M | -186.1% |
| Free Cash Flow | $126.6M | +98.5% |
| +162.5% |
| EPS (Diluted) | $0.82 | +164.5% |
| Stockholders' Equity |
| $1.31B |
| +11.4% |